FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018204983> ?p ?o ?g. }

• W2018204983 abstract "Background: Current Her-2 overexpressing cancer therapies are limited by rapid drug resistance development from Trastuzumab (TRZ) treatment or low selectivity and non specific side effects of hepatotoxicity with small molecular tyrosine kinase inhibitors such as lapatinib. N-(2-hydroxypropyl) methacrylamide (HPMA) copolymer-drug conjugates with tailored side-chain composition have demonstrated their clinical potential as tumor targetable chemotherapeutic delivery systems. The present study evaluates the potential of novel HPMA copolymer-TRZ conjugates to enhance the therapeutic index of Her-2 targeted therapy.Material and Methods: HPMA copolymer-TRZ conjugates were synthesized in two steps. In the first step, an HPMA copolymer precursor containing reactive p-nitrophenyl ester (ONp) side chains was synthesized by free radical precipitation polymerization. In the second step a series of polymer precursors were conjugated to varying amounts of TRZ by aminolysis. The feed ratio of TRZ to HPMA copolymer was calculated based on the number of primary amine groups available on TRZ surface as determined spectrophotometrically using the 2,3,6-Tri-nitrobenzenesulfonic acid (TNBS) assay. The copolymer conjugates were characterized by correlating the feed ratio with the degree of conjugation (TNBS assay) and molecular weight distribution (size exclusion chromatography). The antiproliferative action of HPMA copolymer-TRZ conjugates was evaluated on a Her-2 overexpressing BT474 breast cancer cell line. Cell proliferation was quantified by MTT assay. Activation of Her-2 after treatment with polymer conjugate was measured by western immunoblotting.Results and Discussion: A series of three HPMA copolymer-TRZ conjugates were successfully synthesized and characterized. It was observed that an increase in the feed ratio of HPMA copolymer precursor to TRZ resulted in a corresponding increase in the degree of TRZ conjugation. The size exclusion chromatography profile of the conjugates was also consistent with the degree of conjugation. As HPMA copolymer precursor contents increased, the elution time decreased suggesting an increase in the hydrodynamic volume of conjugates. The growth inhibition effects of all HPMA copolymer-TRZ conjugates were concentration dependant. The half maximal inhibitory concentrations (IC 50 ) of the conjugates with TRZ/HPMA=1/1, 2/1 and 4/1 were 10, 29, and 20 nM respectively, which were comparable to that of free TRZ (8 nM) suggesting that the antibody retained bioactivity against Her-2 overexpressing cancer cells upon conjugation to the polymer. Western immunoblotting showed that polymer conjugated TRZ effectively downregulated activated Her-2 (phospho-Her2) to a greater extent than free TRZ.Conclusion: Here we report for the first time, the successful synthesis, characterization and in vitro evaluation of HPMA copolymer-anti-Her-2 drug (TRZ) conjugates for active targeting to Her-2 overexpressing breast cancer cells. The conjugate compositions were consistent with their molar feed ratios and inhibited model cancer cell growth comparable to the free drug. Preliminary studies indicate improved efficacy of TRZ against Her-2 positive breast cancer cells when administered as polymeric conjugate. Citation Information: Cancer Res 2009;69(24 Suppl):Abstract nr 5065." @default.
• W2018204983 created "2016-06-24" @default.
• W2018204983 creator A5018533808 @default.
• W2018204983 creator A5027709205 @default.
• W2018204983 creator A5070862843 @default.
• W2018204983 creator A5072945710 @default.
• W2018204983 date "2009-12-15" @default.
• W2018204983 modified "2023-09-27" @default.
• W2018204983 title "Synthesis and Characterization of Her-2 Targetable N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates." @default.
• W2018204983 doi "https://doi.org/10.1158/0008-5472.sabcs-09-5065" @default.
• W2018204983 hasPublicationYear "2009" @default.
• W2018204983 type Work @default.
• W2018204983 sameAs 2018204983 @default.
• W2018204983 citedByCount "0" @default.
• W2018204983 crossrefType "proceedings-article" @default.
• W2018204983 hasAuthorship W2018204983A5018533808 @default.
• W2018204983 hasAuthorship W2018204983A5027709205 @default.
• W2018204983 hasAuthorship W2018204983A5070862843 @default.
• W2018204983 hasAuthorship W2018204983A5072945710 @default.
• W2018204983 hasConcept C134306372 @default.
• W2018204983 hasConcept C15920480 @default.
• W2018204983 hasConcept C178790620 @default.
• W2018204983 hasConcept C185592680 @default.
• W2018204983 hasConcept C197336794 @default.
• W2018204983 hasConcept C21951064 @default.
• W2018204983 hasConcept C2775961978 @default.
• W2018204983 hasConcept C2779402116 @default.
• W2018204983 hasConcept C2780783641 @default.
• W2018204983 hasConcept C33923547 @default.
• W2018204983 hasConcept C521977710 @default.
• W2018204983 hasConcept C55493867 @default.
• W2018204983 hasConcept C62112901 @default.
• W2018204983 hasConceptScore W2018204983C134306372 @default.
• W2018204983 hasConceptScore W2018204983C15920480 @default.
• W2018204983 hasConceptScore W2018204983C178790620 @default.
• W2018204983 hasConceptScore W2018204983C185592680 @default.
• W2018204983 hasConceptScore W2018204983C197336794 @default.
• W2018204983 hasConceptScore W2018204983C21951064 @default.
• W2018204983 hasConceptScore W2018204983C2775961978 @default.
• W2018204983 hasConceptScore W2018204983C2779402116 @default.
• W2018204983 hasConceptScore W2018204983C2780783641 @default.
• W2018204983 hasConceptScore W2018204983C33923547 @default.
• W2018204983 hasConceptScore W2018204983C521977710 @default.
• W2018204983 hasConceptScore W2018204983C55493867 @default.
• W2018204983 hasConceptScore W2018204983C62112901 @default.
• W2018204983 hasLocation W20182049831 @default.
• W2018204983 hasOpenAccess W2018204983 @default.
• W2018204983 hasPrimaryLocation W20182049831 @default.
• W2018204983 hasRelatedWork W1970499331 @default.
• W2018204983 hasRelatedWork W1974797103 @default.
• W2018204983 hasRelatedWork W2034746561 @default.
• W2018204983 hasRelatedWork W2035318242 @default.
• W2018204983 hasRelatedWork W2040426912 @default.
• W2018204983 hasRelatedWork W2043028694 @default.
• W2018204983 hasRelatedWork W2055411013 @default.
• W2018204983 hasRelatedWork W2075436600 @default.
• W2018204983 hasRelatedWork W2139910641 @default.
• W2018204983 hasRelatedWork W2140267121 @default.
• W2018204983 hasRelatedWork W2168350093 @default.
• W2018204983 hasRelatedWork W2417628870 @default.
• W2018204983 hasRelatedWork W2540721161 @default.
• W2018204983 hasRelatedWork W2614391499 @default.
• W2018204983 hasRelatedWork W2767796162 @default.
• W2018204983 hasRelatedWork W2950239332 @default.
• W2018204983 hasRelatedWork W2961808134 @default.
• W2018204983 hasRelatedWork W3162924348 @default.
• W2018204983 hasRelatedWork W3197016216 @default.
• W2018204983 hasRelatedWork W3200173403 @default.
• W2018204983 isParatext "false" @default.
• W2018204983 isRetracted "false" @default.
• W2018204983 magId "2018204983" @default.
• W2018204983 workType "article" @default.